Indication: MRI enhancement of the central nervous system and other parts. For normal brain tissue, there is no enhancement due to the presence of the blood-brain barrier; but the dura mater, choroid plexus, and pituitary gland may be enhanced. In addition to the central nervous system, other parts can also be applied. It can significantly increase the signal intensity of liver cancer and hepatic vascular cysts; distinguish liver cysts from normal liver tissue; diagnose or differentiate acute, subacute and chronic myocardial infarction, congenital heart disease, and dissecting aneurysms; it is also helpful for the diagnosis of nasopharyngeal carcinoma, breast cancer, and kidney tumors.

Indication: It is clinically applicable to ventricular and supraventricular tachycardia and premature beats, paroxysmal atrial flutter and fibrillation, preexcitation syndrome, etc. It can also be used for patients with arrhythmias accompanied by congestive heart failure and acute myocardial infarction. It can also be effective for refractory paroxysmal tachycardia that is ineffective with other β-receptor blockers. In addition, it is also used to treat chronic coronary artery insufficiency and angina pectoris.

Indication: Electrolyte supplement. It can be used as an adjuvant treatment for hypokalemia, arrhythmias (mainly ventricular arrhythmias) caused by digitalis poisoning, and sequelae of myocarditis, congestive heart failure, and myocardial infarction.

Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.

Indication: This product is mainly used for thrombolytic therapy of thromboembolic diseases. Including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.

Indication: Used to treat and prevent angina attacks, and as emergency treatment before admission to hospital for patients with acute myocardial infarction combined with left heart failure and pulmonary edema.

Indication: Used to treat and prevent angina attacks, and as emergency treatment before admission to hospital for patients with acute myocardial infarction combined with left heart failure and pulmonary edema.

Indication: (1) Analgesic and antipyretic: It can relieve mild or moderate pain, such as headache, toothache, neuralgia, muscle pain and menstrual pain. It is also used to reduce fever for colds and flu. This product can only relieve symptoms and cannot treat the cause of pain and fever, so other drugs must be used at the same time to treat the cause. (2) Anti-inflammatory and anti-rheumatic: It is a commonly used drug for the treatment of rheumatic fever. It can reduce fever, improve joint symptoms and reduce erythrocyte sedimentation rate, but it cannot eliminate the basic pathological changes of rheumatic fever, nor can it treat and prevent heart damage and other complications. (3) Arthritis: In addition to rheumatoid arthritis, this product is also used to treat rheumatoid arthritis and can improve symptoms, but the cause must be treated at the same time. In addition, this product is also used for osteoarthritis, ankylosing spondylitis, juvenile arthritis and other non-rheumatic inflammatory diseases.

Indication: It is used for acute and chronic hepatitis, idiopathic thrombocytopenic purpura, leukocytopenia and thrombocytopenia caused by chemotherapy and radiotherapy; it has a certain auxiliary therapeutic effect on oliguria and uremia caused by coronary artery sclerosis, chronic arteritis, myocardial infarction, and renal insufficiency. This product is a coenzyme for acetylation reaction, redox reaction and energy metabolism in the human body, and plays an important role in the metabolism of sugar, fat and protein in the body. It is suitable for the treatment of acute and chronic hepatitis, idiopathic thrombocytopenic purpura, leukocytopenia caused by chemotherapy and radiotherapy; it can be used as an auxiliary therapeutic drug for oliguria and uremia caused by coronary artery sclerosis, chronic arteritis, myocardial infarction, and renal insufficiency.

Indication: 1. Hyperlipidemia (1) For patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia or mixed hypercholesterolemia, when dietary control and other non-drug treatments are not ideal, simvastatin can be used to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B and triglycerides. Simvastatin also increases high-density lipoprotein cholesterol, thereby reducing the ratio of low-density lipoprotein/high-density lipoprotein and total cholesterol/high-density lipoprotein. (2) For patients with homozygous familial hypercholesterolemia, when dietary control and non-dietary treatments are not ideal, simvastatin can be used to reduce elevated total cholesterol, low-density lipoprotein cholesterol and apolipoprotein B. 2. Coronary heart disease. (1) Reduce the risk of death. (2) Reduce the risk of death from coronary heart disease and non-fatal myocardial infarction. (3) Reduce the risk of stroke and transient ischemic attack. (4) Reduce the risk of myocardial revascularization surgery (coronary artery bypass grafting and percutaneous balloon coronary angioplasty). (5) Delay the progression of atherosclerosis, including the occurrence of new lesions and complete blockage.